The PRISME team is composed of physicists, biochemists, biologists and radiotherapists. We specialize in multidisciplinary research aimed at developing, optimizing and controlling innovative radiotherapies, whether it be hadrontherapy or therapies using radioactive ion-emitting elements or nanoparticles. These radiotherapies aim to improve the treatment of certain cancers by increasing the effect of ionizing radiation in the tumor while minimizing its harmful effects on healthy tissues.

Our multidisciplinary approach aims to quantify, understand and predict the effect of ionizing radiation on living organisms from processes induced at extremely short times (attosecond) at small scales (atomic nucleus) to long-term consequences (years) at the patient level.
We therefore design and carry out irradiation experiments on targets ranging from molecules or cells to small animals and patient samples (tumor, blood). These experiments feed an important part of our activity which consists in modeling the effects of radiation on living organisms.

One of the innovative techniques of radiotherapy is hadrontherapy, which is to send
an ion beam on the tumors to destroy them. We are working, in particular using simulations, data processing and predictions, to improve these systems by having on-line control over irradiation using dedicated detectors. These tools also have applications in imaging.

The activities can be divided into three research areas:

Axis 1 aims to develop simulations and detectors to control patient irradiation by detecting the particles emitted during hadrontherapy treatment. These developments also offer application prospects in the field of diagnostic imaging.

Axis 2 focuses on the development of multi-scale models and simulations to describe and predict the physical, chemical and biological processes induced by irradiation. It also develops irradiation and dosimetric control means for the measurement of radiobiological effects.

Axis 3 quantifies by experiment the effects induced by irradiation with molecular, cellular, multicellular, in-vitro or in-vivo systems. It focuses on the specificities of innovative radiotherapies and the personalization of care.

8790 documents

  • Albert M Sirunyan, Armen Tumasyan, Wolfgang Adam, Federico Ambrogi, Thomas Bergauer, et al.. Searches for physics beyond the standard model with the M_\mathrm{T2} variable in hadronic final states with and without disappearing tracks in proton-proton collisions at \sqrt{s}= 13 TeV. Eur.Phys.J.C, 2020, 80 (1), pp.3. ⟨10.1140/epjc/s10052-019-7493-x⟩. ⟨hal-02317317⟩
  • Albert M Sirunyan, Armen Tumasyan, Wolfgang Adam, Federico Ambrogi, Thomas Bergauer, et al.. Search for production of four top quarks in final states with same-sign or multiple leptons in proton-proton collisions at \sqrt{s}= 13 TeV. Eur.Phys.J.C, 2020, 80 (2), pp.75. ⟨10.1140/epjc/s10052-019-7593-7⟩. ⟨hal-02302938⟩
  • Albert M Sirunyan, Armen Tumasyan, Wolfgang Adam, Federico Ambrogi, Thomas Bergauer, et al.. Measurements of production cross sections of WZ and same-sign WW boson pairs in association with two jets in proton-proton collisions at \sqrt{s} = 13 TeV. Phys.Lett.B, 2020, 809, pp.135710. ⟨10.1016/j.physletb.2020.135710⟩. ⟨hal-02628066⟩
  • V. Andreev, A. Baghdasaryan, A. Baty, K. Begzsuren, A. Belousov, et al.. Measurement of Exclusive \pi^{+}\pi^{-} and \rho^0 Meson Photoproduction at HERA. European Physical Journal C: Particles and Fields, 2020, 80 (12), pp.1189. ⟨10.1140/epjc/s10052-020-08587-3⟩. ⟨hal-02886864⟩
  • Samuel Gessen, Elisabeth Daguenet, Mathilde Gras, Safa Louati, Wafa Bouleftour, et al.. How to improve clinical research in a department of radiation oncology. Bulletin du Cancer, 2020, 107 (10), pp.991-998. ⟨10.1016/j.bulcan.2020.06.007⟩. ⟨hal-03107897⟩
  • J. Kopyra, Franck Rabilloud, Hassan Abdoul-Carime. Core-excited resonances initiated by unusually low energy electrons observed in dissociative electron attachment to Ni(II) (bis)acetylacetonate. J.Chem.Phys., 2020, 153 (12), pp.124302. ⟨10.1063/5.0023716⟩. ⟨hal-02955777⟩
  • Shreyasi Acharya, Dagmar Adamova, Souvik Priyam Adhya, Alexander Adler, Jonatan Adolfsson, et al.. Measurement of electrons from semileptonic heavy-flavour hadron decays at midrapidity in pp and Pb-Pb collisions at \sqrt{s_{\rm{NN}}} = 5.02 TeV. Phys.Lett.B, 2020, 804, pp.135377. ⟨10.1016/j.physletb.2020.135377⟩. ⟨hal-02372413⟩
  • Shreyasi Acharya, Dagmar Adamova, Alexander Adler, Jonatan Adolfsson, Madan Mohan Aggarwal, et al.. Probing the effects of strong electromagnetic fields with charge-dependent directed flow in Pb-Pb collisions at the LHC. Phys.Rev.Lett., 2020, 125 (2), pp.022301. ⟨10.1103/PhysRevLett.125.022301⟩. ⟨hal-02371636⟩
  • Shreyasi Acharya, Dagmar Adamova, Souvik Priyam Adhya, Alexander Adler, Jonatan Adolfsson, et al.. Global polarization of \Lambda \bar \Lambda hyperons in Pb-Pb collisions at \sqrt {s_{NN}} = 2.76 and 5.02 TeV. Physical Review C, 2020, 101 (4), pp.044611. ⟨10.1103/PhysRevC.101.044611⟩. ⟨hal-02309002⟩
  • Shreyasi Acharya, Dagmar Adamova, Souvik Priyam Adhya, Alexander Adler, Jonatan Adolfsson, et al.. Multiplicity dependence of light (anti-)nuclei production in p-Pb collisions at \sqrt{s_{\rm{NN}}} = 5.02 TeV. Physics Letters B, 2020, 800, pp.135043. ⟨10.1016/j.physletb.2019.135043⟩. ⟨hal-02165504⟩